Se trata del primer metanálisis con datos de participantes individuales que armoniza información clínica y de laboratorio de casi 10.000 embarazadas en 11 países.
Read moreLa XXV edición del Programa Farma-Biotech, que busca fomentar la investigación preclínica y traslacional, se ha centrado en esta ocasión en proyectos de Cataluña
Read moreA team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression o...
Read moreEl grupo de investigación ‘Desarrollo y enfermedades musculares’ del Centro Andaluz de Biología del Desarrollo logra corregir alteraciones fisiopatológicas en modelos celulares de esta grave en...
Read moreIt has been today announced that they has received “Decision to grant” communications from the Canadian Intellectual Property Office and the Israel Patent Office for its patent applications CA3071...
Read moreThe U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral Sclerosis (ALS) developed at the Universitat Autònoma de Barcelona and li...
Read moreUsing functional magnetic resonance imaging (fMRI), the researchers plan to collect the largest dataset to date on indecisiveness in OCD and jump to conclusions in schizophrenia.
Read moreThe study, published in Advanced Science, constitutes a valuable resource to find compounds with therapeutic potential for neurodegenerative diseases.
Read moreEste dispositivo de última generación es la primera vez que se instala en España en un centro de investigación biomédica
Read moreThe origin of some neuropsychiatric diseases, such as autism, bipolar disorder, or depression, and certain neurodegenerative diseases, Alzheimer's and Parkinson's, can be found in very early stages of...
Read moreThe innovative NEOSONICS ultrasound-based tool non-invasively identifies infant meningitis cases with 94% accuracy, potentially transforming current screening protocols based on lumbar puncture
Read moreBetween December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital increase, €7.0 M from commercial bank loans, €13.2 M from the EU-IPCEI grant...
Read more